How Can We Be Sure the New COVID-19 Vaccines Are Safe?
We asked several UCSF experts for a personal take on what will convince them that a vaccine is safe.
University of California San Francisco
Give to UCSFWe asked several UCSF experts for a personal take on what will convince them that a vaccine is safe.
People wear masks as they walk through an outdoor market in Brazil, a country that has seen skyrocketing numbers of COVID-19 cases. Getty ImagesUC San Francisco has spearheaded campaigns across the
A look at past outbreaks offers guidance on bringing the current one to an end – and on thwarting the next one.
Joel Ernst, MD, addresses key questions about how vaccine development works and why vaccines are especially important in the case of COVID-19.
When future historians look back on this moment, they will draw many conclusions from our response to this crisis. Here are five big lessons that UCSF experts already see taking shape.
As cases of COVID-19 continue to mount in Navajo Nation, UC San Francisco is sending a second team of health care workers — 13 nurses and six physicians — to Arizona to help provide urgently needed support to the largest hospitals serving Navajo patients.
Amid so little good news, early clinical trial results for the anti-viral drug remdesivir have offered hope. The drug appeared to help patients recover faster, from 15 days to 11 days. But the newest obstacle may be the uncertainty that surrounds how the drug will be distributed to patients.
New research confirmed the higher rates of early life respiratory infections among Puerto Ricans.
UCSF is launching a workforce training and technical assistance program in partnership with the California Department of Public Health to facilitate the training of thousands of individuals across the state in public health techniques and strategies, including contact tracing, case investigation and administration, to limit the ongoing spread of COVID-19.
To ramp up contact tracing for COVID-19 in San Francisco, UCSF has been partnering with the San Francisco Department of Public Health (SFDPH) to provide technical assistance, training and manpower.
A UCSF researcher is among the team that announced promising Phase 1 clinical results for the first new oral polio vaccine in 50 years.